Page 1685 - Coronavirus

Govt to soon come out with a list of strategic sectors: DEA Secretary

Finance Minister Nirmala Sitharaman had in May announced that there will be a maximum of four public sector companies in strategic sectors

Govt to ensure regulatory facilitation for Serum's Covid-19 vaccine trials

Serum Institute of India, the largest vaccine manufacturer in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it gets ready.

Bankers divided on extending moratorium, fear potential spike in bad loans

Without regulatory intervention, slippages could surge 300 bps

We want to price Covid-19 vaccine below Rs 1,000: Serum Institute CEO

Pune's Serum Institute of India is placing its bets on the Oxford-AstraZeneca vaccine candidate AZD1222

Govt extends work from home norms for IT, BPO companies till December 31

Currently, around 85 per cent of the IT workforce is working from home and only those performing critical functions are going to offices

GSK merger helps HUL's top line, but profit before tax down 6% in Q1

Excluding the GSK business, overall revenue declined 7 per cent in the quarter, Srinivas Phatak, chief financial officer, HUL, said in a virtual press meet

Covid-19 impact: India's GDP to contract 6.1% in FY21, says Nomura

Nomura said the June quarter will be the 'nadir' from a growth perspective and the economy will contract by 15.2 per cent

Serum Institute to begin trials of Oxford's Covid-19 vaccine by August-end

The varsity has tied up with Serum Institute of India (SII) to manufacture and supply the vaccine to India and over 60 other countries having a combined population of 3 billion

Letter to BS: Covid taught us how we lag in application of microeconomics

The unique problem amid Covid-19 is that every sector has been eroded of wealth and the ability to create it

Lucknow Police to start 'masking drive' in the city, procures 50,000 masks

While offenders are liable to pay Rs 500 as penalty for not wearing masks, they are also supposed to buy two masks for Rs 10 on the spot

Covid-19 impact: Trujet reduces salaries of employees by minimum 50%

The airline said it is "facing serious financial crunch/cash flow situation"

Covid-19 lockdown takes the fizz out of Coke's operations in June quarter

Global volume offtake dropped 16 per cent year-on-year (YoY) and its aerated drinks business fell 12 per cent YoY, with the lockdown being the major factor.

LinkedIn slashing about 960 jobs globally amid Covid-19 pandemic

The company, which is part of tech giant Microsoft, has about 1,200 employees in India. It also has a development centre in Bengaluru.

FabiFlu cheaper than other drugs to treat Covid-19, claims Glenmark

The company further claimed that since favipiravir was an oral therapy, patients could be treated on an out-patient basis without incurring additional hospitalisation expenses

Biocon diversifies business model, enters digital therapeutic segment

To launch Insulia for at-home management of diabetes in collaboration with Voluntis

US wants to build coalition to counter China's 'disgraceful' menace: Pompeo

US President Donald Trump identifies China as the United States' main rival, and has accused President Xi Jinping of taking advantage over trade and not telling the truth over the novel Covid outbreak

Covid-19 crisis: Russian elite got access to experimental vaccine

The Gamaleya vaccine, financed by the state-run Russian Direct Investment Fund and backed by the Defense Ministry, last week completed a phase 1 trial involving military personnel.

Russia is a highly capable cyber actor, says UK intelligence report

"Russia is a highly capable cyber actor, employing organised crime groups to supplement its cyber skills," the report published by the UK's Intelligence and Security Committee on Tuesday, said.

China used Covid-19 distraction in attempt to seize Indian land: US

The NDAA amendment, moved by Congressman Steve Chabot along with lawmaker Ami Bera and passed on Monday, said that India and China should work towards de-escalating the situation along the LAC.

IRDAI allows insurers to sell Corona Kavach policy as group product

Each insurer can price the product according to its risk assessment, health portfolio and its claim experience.